PushCART Therapeutics, Inc.
PrivateLast Round
Seed
Jul 31, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PushCART Therapeutics, Inc. is a biotechnology company that develops cell therapies designed to treat solid tumors by enabling immune cells to penetrate dense fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PushCART Therapeutics, Inc. Comparables
Compare PushCART Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inceptor Bio | 80% | |
| Innovative Cellular Therapeutics | 77% | |
| Dispatch Biotherapeutics | 76% | |
PushCART Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 31, 2026 | ||||
| Seed | Apr 27, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2026
$500K Seed Round raised.
- Apr 27, 2026
Completed a Seed funding round.
PushCART Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PushCART Therapeutics, Inc.'s valuation, stock price, and market status.